Published online before print August 25, 2003, doi: 10.1161/01.CIR.0000087598.05977.45
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:1362.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
Cerebral Venous Thrombosis in Children
A Multifactorial Origin
From the Department of Pediatrics/Pediatric Hematology & Oncology, University of Frankfurt am Main (C.H.), Dresden (R.K.), Münster (A.K., R.S., U.N.-G.), Munich (K.K.), Halle (R.S.), and Freiburg (B.Z.), Germany; Institute of Medical Informatics and Biomathematics (A.H.) and Institute of Clinical Chemistry and Institute of Arteriosclerosis Research (R.J.), University of Münster, Münster, Germany; and Institute of Clinical Chemistry, University of Zürich (A.v.E.), Zürich, Switzerland.
Correspondence to Prof Dr U. Nowak-Göttl, Department of Pediatric Hematology and Oncology, Westfälische Wilhelms-Universität Münster, Albert-Schweitzer-Straße 33, D-48149 Münster, Germany. E-mail leagottl{at}uni-muenster.de
Received February 11, 2003; de novo received April 16, 2003; revision received June 23, 2003; accepted June 23, 2003.
Background— The present study was performed to assess the association of prothrombotic risk factors and underlying conditions (infections, vascular trauma, immobilization, malignancies, autoimmune diseases, renal diseases, metabolic disorders, obesity, birth asphyxia, cardiac malformations, and use of prothrombotic drugs) with cerebral venous thrombosis (CVT) in children.
Methods and Results— From 1995 to 2002, 149 pediatric patients aged newborn to <18 years (median 6 years) with CVT were consecutively enrolled. In patients and in 149 age- and gender-matched children with similar underlying clinical conditions but without CVT, the factor V G1691A mutation, the factor II G20210A variant, lipoprotein(a) [Lp(a)], protein C, protein S, antithrombin, and antiphospholipid antibodies, as well as associated clinical conditions, were investigated. Eighty-four (56.4%) of the patients had at least 1 prothrombotic risk factor compared with 31 control children (20.8%; P<0.0001). In addition, 105 (70.5%) of 149 patients with CVT presented with an underlying predisposing condition. On univariate analysis, factor V, protein C, protein S, and elevated Lp(a) were found to be significantly associated with CVT. However, in multivariate analysis, only the combination of a prothrombotic risk factor with an underlying condition (OR 3.9, 95% CI 1.8 to 8.6), increased Lp(a) (OR 4.1, 95% CI 2.0 to 8.7), and protein C deficiency (OR 11.1, 95% CI 1.2 to 104.4) had independent associations with CVT in the children investigated.
Conclusions— CVT in children is a multifactorial disease that, in the majority of cases, results from a combination of prothrombotic risk factors and/or underlying clinical condition.
Key Words: pediatrics • lipoproteins • thrombosis
This article has been cited by other articles:
 |
|
 |
|
  T. Sipahi, S. Karademir, A. Kuybulu, and N. Akar Diffuse Cerebral Infarct Associated With Factor V Leiden and Prothrombin 20210A Mutations in a Patient With Tetralogy of Fallot Clinical and Applied Thrombosis/Hemostasis, December 1, 2009; 15(6): 705 - 707. [Abstract] [PDF]
|
|
|
|
 |
|
 A A Mallick, P M Sharples, S E Calvert, R W A Jones, M Leary, A L Lux, F J O'Callaghan, J P Osborne, J S Patel, A T Prendiville, et al. Cerebral venous sinus thrombosis: a case series including thrombolysis Arch. Dis. Child., October 1, 2009; 94(10): 790 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Teksam, M. Moharir, G. deVeber, and M. Shroff Frequency and Topographic Distribution of Brain Lesions in Pediatric Cerebral Venous Thrombosis AJNR Am. J. Neuroradiol., November 1, 2008; 29(10): 1961 - 1965. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J Pappachan and F J Kirkham Cerebrovascular disease and stroke Arch. Dis. Child., October 1, 2008; 93(10): 890 - 898. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Young, M. Albisetti, M. Bonduel, L. Brandao, A. Chan, F. Friedrichs, N. A. Goldenberg, E. Grabowski, C. Heller, J. Journeycake, et al. Impact of Inherited Thrombophilia on Venous Thromboembolism in Children: A Systematic Review and Meta-Analysis of Observational Studies Circulation, September 23, 2008; 118(13): 1373 - 1382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Roach, M. R. Golomb, R. Adams, J. Biller, S. Daniels, G. deVeber, D. Ferriero, B. V. Jones, F. J. Kirkham, R. M. Scott, et al. Management of Stroke in Infants and Children: A Scientific Statement From a Special Writing Group of the American Heart Association Stroke Council and the Council on Cardiovascular Disease in the Young Stroke, September 1, 2008; 39(9): 2644 - 2691. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 887S - 968S. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Wasay, A. I. Dai, M. Ansari, Z. Shaikh, and E.S. Roach Cerebral Venous Sinus Thrombosis in Children: A Multicenter Cohort From the United States J Child Neurol, January 1, 2008; 23(1): 26 - 31. [Abstract] [PDF]
|
|
|
|
|
|
V. Ganesan, M. Prengler, A. Wade, and F. J. Kirkham Clinical and Radiological Recurrence After Childhood Arterial Ischemic Stroke Circulation, November 14, 2006; 114(20): 2170 - 2177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Sebire, B. Tabarki, D. E. Saunders, I. Leroy, R. Liesner, C. Saint-Martin, B. Husson, A. N. Williams, A. Wade, and F. J. Kirkham Cerebral venous sinus thrombosis in children: risk factors, presentation, diagnosis and outcome Brain, March 1, 2005; 128(3): 477 - 489. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Ferriero Neonatal Brain Injury N. Engl. J. Med., November 4, 2004; 351(19): 1985 - 1995. [Full Text] [PDF]
|
|
|
|
 |
|
 A. Kosch, E. Kuwertz-Broking, C. Heller, K. Kurnik, R. Schobess, and U. Nowak-Gottl Renal venous thrombosis in neonates: prothrombotic risk factors and long-term follow-up Blood, September 1, 2004; 104(5): 1356 - 1360. [Abstract] [Full Text] [PDF]
|
|